Summary
University of North Carolina (UNC) is an educational service provider that offers various academic courses and research services. The university provides academic programs such as academic program inventory, distance education inventory, academic common market, certificate inventory, UNC online, professional science master's degrees and inter-institutional registration. It offers graduate programs in masters, professional and doctoral levels. UNC's graduate council provides recommendations for developing new data, research and communication strategies for graduate education. The university also offers targeted funding for potentially promising research projects. It operates through its various campuses across the US. UNC is headquartered in Chapel Hill, North Carolina, the US.
University of North Carolina - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
'
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
University of North Carolina, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
University of North Carolina, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
University of North Carolina, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
University of North Carolina, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8
University of North Carolina, Medical Devices Deals, 2010 to YTD 2016 9
University of North Carolina, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 10
University of North Carolina, Pharmaceuticals & Healthcare, Deal Details 12
Partnerships 12
University of North Carolina Forms Joint Venture with GlaxoSmithKline 12
Antitope Enters Into Co-Development Agreement With The University Of North Carolina 14
Licensing Agreements 15
Abeona Therapeutics Enters into Licensing Agreement with University of North Carolina at Chapel Hill 15
Mucommune Enters into Licensing Agreement with UNC Eshelman School of Pharmacy 16
Proove Biosciences Enters into Licensing Agreement with University of North Carolina at Chapel Hill School of Dentistry 17
New Paradigm Therapeutics Enters into Licensing Agreement with University of Maine and University of North Carolina 18
Meryx Enters into Licensing Agreement with UNC Eshelman School of Pharmacy 19
Spyryx Biosciences Enters into Licensing Agreement with University of North Carolina at Chapel Hill 20
Immune Design Enters into Licensing Agreement with UNC Chapel Hill 21
Capture Pharma Enters into Licensing Agreement with University of North Carolina 22
Qualiber Enters into Licensing Agreement with University of North Carolina 23
Synereca Pharma Enters into Licensing Agreement with University of North Carolina 24
Asset Transactions 25
Bamboo Therapeutics Acquires Viral Gene Therapy Manufacturing Facility from University of North Carolina 25
University of North Carolina - Key Competitors 26
Key Employees 27
Locations And Subsidiaries 29
Head Office 29
Other Locations & Subsidiaries 29
Appendix 32
Methodology 32
About GlobalData 32
Contact Us 32
Disclaimer 32
List of Tables
University of North Carolina, Pharmaceuticals & Healthcare, Key Facts 1
University of North Carolina, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
University of North Carolina, Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
University of North Carolina, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
University of North Carolina, Deals By Therapy Area, 2010 to YTD 2016 8
University of North Carolina, Medical Devices Deals, 2010 to YTD 2016 9
University of North Carolina, Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 10
University of North Carolina Forms Joint Venture with GlaxoSmithKline 12
Antitope Enters Into Co-Development Agreement With The University Of North Carolina 14
Abeona Therapeutics Enters into Licensing Agreement with University of North Carolina at Chapel Hill 15
Mucommune Enters into Licensing Agreement with UNC Eshelman School of Pharmacy 16
Proove Biosciences Enters into Licensing Agreement with University of North Carolina at Chapel Hill School of Dentistry 17
New Paradigm Therapeutics Enters into Licensing Agreement with University of Maine and University of North Carolina 18
Meryx Enters into Licensing Agreement with UNC Eshelman School of Pharmacy 19
Spyryx Biosciences Enters into Licensing Agreement with University of North Carolina at Chapel Hill 20
Immune Design Enters into Licensing Agreement with UNC Chapel Hill 21
Capture Pharma Enters into Licensing Agreement with University of North Carolina 22
Qualiber Enters into Licensing Agreement with University of North Carolina 23
Synereca Pharma Enters into Licensing Agreement with University of North Carolina 24
Bamboo Therapeutics Acquires Viral Gene Therapy Manufacturing Facility from University of North Carolina 25
University of North Carolina, Key Competitors 26
University of North Carolina, Key Employees 27
University of North Carolina, Other Locations 29
University of North Carolina, Subsidiaries 30
List of Figures
University of North Carolina, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 1
University of North Carolina, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 1
University of North Carolina, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 1
University of North Carolina, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 1
University of North Carolina, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
University of North Carolina, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 6
University of North Carolina, Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
University of North Carolina, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8
University of North Carolina, Medical Devices Deals, 2010 to YTD 2016 9
